What causes axial spondyloarthritis

Overview

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that primarily affects the spine and the sacroiliac joints (where the spine connects to the pelvis). It is a type of inflammatory arthritis that belongs to the spondyloarthritis family. The hallmark of axSpA is inflammation that can lead to pain and stiffness in the lower back and hips, particularly worse in the morning or after periods of inactivity. Over time, this inflammation can cause new bone to form, leading to the fusing of vertebrae, a process known as "ankylosis," which can result in reduced mobility and posture changes.

Understanding the causes of axSpA involves looking at a combination of factors, with genetics playing a significant role, alongside environmental influences. While the disease is not directly inherited, certain genes significantly increase an individual's risk of developing it. The immune system's response is central to the pathogenesis of axSpA, as it mistakenly targets the body's own tissues, leading to chronic inflammation.

Genetics: The HLA-B27 Gene

The most significant genetic factor associated with axial spondyloarthritis is the presence of the Human Leukocyte Antigen B27 (HLA-B27) gene. HLA genes are part of the major histocompatibility complex (MHC) and play a crucial role in the immune system by helping it distinguish between the body's own proteins and foreign invaders, like bacteria or viruses. They present antigen fragments to T cells, initiating an immune response.

In the context of axSpA, the HLA-B27 protein is thought to contribute to the disease process in several ways:

• Immune Dysregulation: It may alter the way immune cells recognize and respond to certain signals, potentially leading to an inappropriate inflammatory response.
• Molecular Mimicry: Some researchers believe that certain bacteria or viruses might have proteins that resemble parts of the HLA-B27 protein. The immune system, while trying to fight off the infection, might mistakenly attack the body's own tissues expressing HLA-B27.
• Direct Inflammatory Effects: The HLA-B27 protein itself, or certain forms of it, might directly trigger inflammatory pathways within cells.

It is crucial to understand that while HLA-B27 is strongly linked to axSpA, not everyone who has the gene will develop the condition. Only a small percentage of individuals with HLA-B27 go on to develop axSpA. This highlights the importance of other contributing factors.

Other Genetic Factors

Beyond HLA-B27, other genes have been identified that may influence the risk of developing axSpA. These genes are often involved in regulating the immune system, controlling inflammation, or bone metabolism. Examples include genes involved in the production of cytokines (signaling molecules of the immune system), such as IL-23R, and other immune-related genes. The cumulative effect of multiple genetic variations can increase susceptibility.

Environmental Triggers

While genetics provides the predisposition, it is widely believed that environmental factors act as triggers, initiating the inflammatory cascade in susceptible individuals. The exact nature of these triggers is still an area of active research, but several possibilities are being explored:

• Gut Microbiome Dysbiosis: The balance of bacteria and other microorganisms in the gut (the microbiome) plays a vital role in immune system function. Changes in the gut microbiome, known as dysbiosis, have been observed in individuals with axSpA. It's hypothesized that this imbalance could lead to increased intestinal permeability ("leaky gut"), allowing bacterial products to enter the bloodstream and trigger systemic inflammation.
• Infections: Certain bacterial infections, particularly those affecting the gastrointestinal or genitourinary tracts, have been implicated. The theory of molecular mimicry, mentioned earlier in relation to HLA-B27, is relevant here, suggesting that the immune response to an infection could cross-react with self-antigens.
• Other Unknown Factors: It's possible that other environmental exposures, such as specific viruses, toxins, or even lifestyle factors, could play a role, though these are less clearly defined.

The Role of the Immune System

Axial spondyloarthritis is classified as an autoimmune or autoinflammatory disease. In axSpA, the immune system, which is designed to protect the body from pathogens, becomes dysregulated. Instead of targeting foreign invaders, it mistakenly attacks components of the body's own tissues, particularly the entheses – the sites where tendons and ligaments attach to bone. This inflammation at the entheses, especially in the spine and sacroiliac joints, is a key feature of the disease.

Specific immune cells and inflammatory mediators (cytokines) are implicated in this process. For instance, the IL-17 and TNF-alpha pathways are known to be overactive in axSpA and are targets for many of the biologic therapies used to treat the condition.

Unanswered Questions and Future Research

Despite significant advances, the precise mechanisms by which genetic and environmental factors interact to cause axSpA are not fully understood. Key areas of ongoing research include:

• Identifying specific environmental triggers with greater certainty.
• Elucidating the exact role of the gut microbiome in disease initiation and progression.
• Understanding how HLA-B27 contributes to inflammation at a molecular level.
• Exploring the roles of other genetic factors beyond HLA-B27.

Continued research in these areas is crucial for developing more effective preventative strategies and targeted treatments for axial spondyloarthritis.